wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38193896-CA44D17C-5BDC-44C6-80BE-D6424F216EA7
Q38193896-CA44D17C-5BDC-44C6-80BE-D6424F216EA7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38193896-CA44D17C-5BDC-44C6-80BE-D6424F216EA7
Critical analysis of phase II and III randomised control trials (RCTs) evaluating efficacy and tolerability of a β₃-adrenoceptor agonist (Mirabegron) for overactive bladder (OAB).
P2860
Q38193896-CA44D17C-5BDC-44C6-80BE-D6424F216EA7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38193896-CA44D17C-5BDC-44C6-80BE-D6424F216EA7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c467280afbc451e205fa453441dcb844935a0972
P2860
A phase III, randomized, double-blind, parallel-group, placebo-controlled, multicentre study to assess the efficacy and safety of the β₃ adrenoceptor agonist, mirabegron, in patients with symptoms of overactive bladder.